ACTRN12612000584831已完成2 期
STRIDER (NZAus): A randomised placebo controlled trial of sildenafil therapy to improve fetal growth velocity in dismal prognosis early-onset intrauterine growth restriction (New Zealand and Australia).
niversity of Auckland0 个研究点目标入组 122 人开始时间: 2012年5月30日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- Female
入选标准
- •1. Singleton pregnancy.
- •2a. At 22+0 weeks to 27+6 weeks: AC measure less than or equal to 3 percentile for gestational age; OR
- •2b. At 28+0 weeks to 29+6 weeks ultrasound estimate of fetal weight (EFW) <700grams.
排除标准
- •1. Known major fetal anomaly/syndrome/congenital infection deemed to be the likely cause of IUGR.
- •2. Known fetal aneuploidy.
- •3. Already made plan for termination of pregnancy.
- •4. Maternal disease (e.g. pre-eclampsia) where it is expected that delivery is necessary within 48 hours.
- •5. Any contraindication to sildenafil therapy.
研究者
相似试验
进行中（未招募）
2 期
A targeted community program of vitamin D treatment to reduce hospital admissions for falls, fractures and other disordersFalls in the elderlyFractures in the elderlyMusculoskeletal - Other muscular and skeletal disordersACTRN12609000748213Professor RL Prince660
进行中（未招募）
不适用
A randomised, double-blind, placebo controlled study to assess the safety and the efficacy of neridronate 100 mg - 4 i.v. infusions in a course of 10 days treatment - in patients with algodystrophic syndrome. - NDEUCTR2007-003372-18-ITABIOGEN PHARMA
进行中（未招募）
不适用
A randomised, double-blind, placebo controlled study to evaluate the pharmacodynamics, safety, tolerability and pharmacokinetics profile of SLx-4090 over 14 days dosing in subjects with high triglyceride values.Dyslipidemia/hypertriglyceridemiaMedDRA version: 8.1Level: LLTClassification code 10058110Term: DyslipidemiaEUCTR2007-000536-95-DESurface Logix
进行中（未招募）
1 期
A randomised, double-blind, placebo controlled study of AIMSPRO in Multiple Sclerosis - AIMSPRO in MS bladder functioOveractive Bladder in Secondary Progressive Multiple Sclerosis and the other neurological symptoms associated with Secondary Progressive Multiple SclerosisMedDRA version: 9.1 Level: LLT Classification code 10063400 Term: Secondary progressive multiple sclerosisMedDRA version: 9.1 Level: LLT Classification code 10059617 Term: Overactive bladderMedDRA version: 9.1 Level: LLT Classification code 10012547 Term: Detrusor hyperreflexiaEUCTR2006-006872-39-GBDaval International Limited20
已完成
不适用
A randomised controlled placebo based trial to determine the efficacy of a prophylactic dose of hydrocortisone and anti histamine in preventing reactions to anti snake venom (ASV)Anaphylactoid and pryogenic reactions to anti snake venomInjury, Occupational Diseases, PoisoningReactions to anti snake venomISRCTN29425449St John's Medical College (India)250